by TractManager | Nov 14, 2018 | Emerging Technology Report
Ryplazim is an investigational intravenous plasminogen replacement therapy for treatment of congenital plasminogen deficiency in children and adults. Ryplazim is recovered from healthy donor plasma; plasminogen is extracted using a proprietary process. Purified...
by TractManager | Nov 12, 2018 | Health Technology Assessment
Health Problem: Sacral insufficiency fractures (SIFs) are fragility fractures of the sacrum that destabilize the pelvis and cause debilitating low back pain. The overall incidence of SIF is difficult to determine; however, one estimate suggests that 19%...
by TractManager | Nov 6, 2018 | Precision Therapy Assessment
Health Problem: Respiratory distress syndrome (RDS) is one of the most common causes of preterm infant respiratory failure and mortality, with RDS occurring in 20,000 to 30,000 newborn infants annually in the United States. RDS results from developmental immaturity of...
by TractManager | Nov 6, 2018 | Health Technology Assessment
Health Problem: Respiratory distress syndrome (RDS) is one of the most common causes of preterm infant respiratory failure and mortality, with RDS occurring in 20,000 to 30,000 newborn infants annually in the United States. RDS results from developmental immaturity of...
by TractManager | Nov 1, 2018 | Health Technology Assessment
Health Problem: Acute postoperative pain is common across a variety of surgical procedures, including both hard- and soft-tissue surgeries. Inadequately controlled pain negatively affects quality of life and the recovery of function and may result in an increase in...
Recent Comments